Atul Mehta

Atul Manibhai Mehta (born 13 December 1949) is a former Indian cricketer who played first-class cricket between 1967 and 1981.

Mehta was born in Rangoon, Burma, where his parents owned a business. A batsman and leg-spin bowler, he played Ranji Trophy cricket for Saurashtra, Bombay and Gujarat.

Mehta played in Bombay's victory in the Ranji Trophy final in 1970–71, scoring valuable runs in the lower order in the 48-run victory over Maharashtra. His highest score was 141 for Gujarat against Maharashtra in 1980–81. He was the leading scorer in the low-scoring match with 40 and 37 when Gujarat beat Bombay by 225 runs in 1977–78.

Mehta moved to the United States in the 1980s. He owns a motel in California. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Atul Mehta', query time: 0.05s Refine Results
  1. 1
    Thoracic ultrasound: Picture worth a thousand sounds

    Thoracic ultrasound: Picture worth a thousand sounds by Ajit Moghekar, Atul Mehta

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Broncho-vascular fistulas from self-expanding metallic stents: A retrospective case review

    Broncho-vascular fistulas from self-expanding metallic stents: A retrospective case review by Chirag Choudhary, Debabrata Bandyopadhyay, Reyadh Salman, Thomas Gildea, Atul Mehta

    Published 2013-01-01
    Get full text
    Article
  3. 3
    A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease

    A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease by Monica Hadi, Paul Swinburn, Luba Nalysnyk, Alaa Hamed, Atul Mehta

    Published 2018-09-01
    Get full text
    Article
  4. 4
    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

    A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide by Atul Mehta, Uma Ramaswami, Joseph Muenzer, Roberto Giugliani, Kurt Ullrich, Tanya Collin-Histed, Zoya Panahloo, Hartmann Wellhoefer, Joel Frader

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Human induced pluripotent stem cells generated from Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome patients with a homozygous mutation in the PSMB8 gene (NIHTVBi016-A, NIHTVBi017-A, NIHTVBi018-A)

    Human induced pluripotent stem cells generated from Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome patients with a homozygou... by Quan Yu, Atul Mehta, Jizhong Zou, Jeanette Beers, Adriana A de Jesus Rasheed, Raphaela Goldbach-Mansky, Manfred Boehm, Guibin Chen

    Published 2022-07-01
    Get full text
    Article
  6. 6
    Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

    Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis by Michael Beck, Derralynn Hughes, Christoph Kampmann, Sylvain Larroque, Atul Mehta, Guillem Pintos-Morell, Uma Ramaswami, Michael West, Anna Wijatyk, Roberto Giugliani

    Published 2015-06-01
    Get full text
    Article
  7. 7
    Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene

    Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene by Atul Mehta, Quan Yu, Yangtengyu Liu, Dan Yang, Jizhong Zou, Jeanette Beers, Adriana A de Jesus Rasheed, Andrew T. Rastegar, Raphaela Goldbach-Mansky, Manfred Boehm, Guibin Chen

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.

    Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors. by Maarten Arends, Marieke Biegstraaten, Derralynn A Hughes, Atul Mehta, Perry M Elliott, Daniel Oder, Oliver T Watkinson, Frédéric M Vaz, André B P van Kuilenburg, Christoph Wanner, Carla E M Hollak

    Published 2017-01-01
    Get full text
    Article
  9. 9
    Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.

    Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients. by Brandy Young-Gqamana, Nastry Brignol, Hui-Hwa Chang, Richie Khanna, Rebecca Soska, Maria Fuller, Sheela A Sitaraman, Dominique P Germain, Roberto Giugliani, Derralynn A Hughes, Atul Mehta, Kathy Nicholls, Pol Boudes, David J Lockhart, Kenneth J Valenzano, Elfrida R Benjamin

    Published 2013-01-01
    Get full text
    Article
  10. 10
    In-depth phenotyping for clinical stratification of Gaucher disease

    In-depth phenotyping for clinical stratification of Gaucher disease by Simona D’Amore, Kathleen Page, Aimée Donald, Khadijeh Taiyari, Brian Tom, Patrick Deegan, Chong Y. Tan, Kenneth Poole, Simon A. Jones, Atul Mehta, Derralynn Hughes, Reena Sharma, Robin H. Lachmann, Anupam Chakrapani, Tarekegn Geberhiwot, Saikat Santra, Siddarth Banka, Timothy M. Cox, the MRC GAUCHERITE Consortium

    Published 2021-10-01
    Get full text
    Article

Search Tools: